Delivery Order SPE2DB20D3103-SPE2DB25FM4S2
Award Date
1/27/25
Potential Completion Date
2/18/25
Potential Value
$66K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $41,389.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $44,092.12 firm fixed-price delivery order is for the supply of POLIVY 140 MG VIALS, a pharmaceutical product, with a period of performance through July 3, 2025. The contract is not set-aside and was awarded on June 11, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,046.06, is a Firm Fixed Price Delivery Order to provide POLIVY 140 MG VIALS to support military healthcare programs. The contract has an ultimate completion date of March 17, 2025 and was awarded on February 24, 2025. This award is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564288200 POLIVY 140 MG VIALS to the U.S. government. The contract, valued at $40,304.38, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00...
This is a $20,908.66 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of POLIVY 140 mg vials, a specialty pharmaceutical product. The contract has an ultimate completion date of August 21, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including prescription drugs, medical supplies, and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,631.26 firm fixed-price delivery order is for the supply of POLIVY 140 MG VIALS, with a period of performance through December 18, 2024. This contract is not designated as a set-aside. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $90,574.48 firm fixed-price delivery order is for the supply of POLIVY 140 MG VIALS, a pharmaceutical product. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide POLIVY 140 MG VIALS. The award has a potential value of $20,908.66 and a completion date of March 25, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor on this award and has previously received numerous...
This federal contract award, valued at $10,454.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of POLIVY 140 MG VIALS, a pharmaceutical product, with a completion date of January 29, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $32,817.12 delivery order contract is for the provision of POLIVY 140 MG VIALS, a pharmaceutical product. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to various federal agencies, particularly the...